Aug 02, 2023 / 05:30AM GMT
Presentation
Aug 02, 2023 / 05:30AM GMT
=====================
Corporate Participants
=====================
* Akiko Nakahama
Eisai Co., Ltd. - VP and Chief Portfolio Off. of AD Filing & Reg. - Japan, Asia Lead Quality & Japan Reg. Affairs
* Hideki Toyosaki
* Keisuke Naito
Eisai Co., Ltd. - SVP, Chief Strategy, Planning & Ecosystem Officer and Acting Global Alzheimer's Disease Officer
* Mitsuru Shomon
Eisai Co., Ltd. - VP, CFO and Head of Corporate Finance & Accounting HQs
* Takashi Owa
Eisai Co., Ltd. - Senior VP & Chief Scientific Officer - Japan and Asia Medical Safety
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc. Exchange Research - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
Eisai Co Ltd
(HAM:EII)
€
21.13
+0.25 (+1.2%)
Market Cap: 6.13 Bil
Enterprise Value: 5.94 Bil
PE Ratio: 29.18
PB Ratio: 1.25
GF Score: 64/100 Q1 2024 Eisai Co Ltd Earnings Presentation Transcript
Aug 02, 2023 / 05:30AM GMT
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot